Modulation of mitochondrial function and morphology by interaction of Omi/HtrA2 with the mitochondrial fusion factor OPA1
Open Access
- 1 April 2010
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 316 (7) , 1213-1224
Abstract
No abstract availableKeywords
Funding Information
- German Research Council (KR2119/3-1)
- German National Genome Research Network
This publication has 37 references indexed in Scilit:
- Loss-of-Function Analysis Suggests ThatOmi/HtrA2Is Not an Essential Component of thepink1/parkinPathwayIn VivoJournal of Neuroscience, 2008
- Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress responseCell Death & Differentiation, 2008
- Genetic variation of Omi/HtrA2 and Parkinson's diseaseParkinsonism & Related Disorders, 2008
- Accumulation of HtrA2/Omi in Neuronal and Glial Inclusions in Brains With α-SynucleinopathiesJournal of Neuropathology & Experimental Neurology, 2008
- Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinson’s disease factors Pink1 and ParkinDisease Models & Mechanisms, 2008
- Mpv17l protects against mitochondrial oxidative stress and apoptosis by activation of Omi/HtrA2 proteaseProceedings of the National Academy of Sciences, 2008
- Opa1-Mediated Cristae Opening Is Bax/Bak and BH3 Dependent, Required for Apoptosis, and Independent of Bak OligomerizationMolecular Cell, 2008
- Omi / HtrA2 is relevant to the selective vulnerability of striatal neurons in Huntington’s diseaseEuropean Journal of Neuroscience, 2008
- Genetic variability in the mitochondrial serine proteaseHTRA2contributes to risk for Parkinson diseaseHuman Mutation, 2008
- Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controlsHuman Molecular Genetics, 2008